Anxiety Disorders Recruiting Phase 2 / 3 Trials for Vortioxetine (DB09068)

Also known as: Anxiety Disorder / Anxiety NOS

IndicationStatusPhase
DBCOND0027904 (Anxiety Disorders)Recruiting2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03485274Substance Misuse To Psychiatric Disorders for CannabisTreatment